Target Name: VTRNA1-2
NCBI ID: G56663
Other Name(s): Vault RNA 1-2 | VR2 | vault RNA 1-2 | HVG2 | VAULTRC2 | hvg-2

VTRNA1-2: A Potential Drug Target and Biomarker

Vault RNA 1-2 (VTRNA1-2) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its unique structure and function have made it an attractive target for drug developers. In this article, we will explore the biology of VTRNA1-2 and its potential as a drug target and biomarker.

Structure and Function

Vault RNA 1-2 is a small non-coding RNA molecule that is expressed in various tissues and organs. It has a unique structure that consists of a hairpin loop and a stem-loop. The hairpin loop is the regions that form the stem- loop, which is a repeating unit of RNA secondary structure. The stem-loop is the regions that form the loop, which is a repeating unit of RNA secondary structure.

VTRNA1-2 functions as a negative regulator of gene expression. It interacts with specific target mRNAs and prevents them from being translated into proteins. This interaction between VTRNA1-2 and target mRNAs is critical for the regulation of gene expression and is a key mechanism in the control of gene function.

Drug Target Potential

VTRNA1-2 has been identified as a potential drug target due to its unique structure and function. The hairpin loop and stem-loop regions of VTRNA1-2 make it a stable interaction partner for other molecules. This stability makes it an attractive target for small molecules that can modulate the activity of VTRNA1-2.

One of the potential drugs that can interact with VTRNA1-2 is Puzzle. Jigsaw is a drug used to treat cancer that inhibits the growth and spread of cancer cells by interfering with the interaction of VTRNA1-2 with target mRNAs.

biomarker potential

VTRNA1-2 has also been identified as a potential biomarker for various diseases, including cancer. Its unique structure and function make it an attractive target for diagnostic tools that can detect and measure the expression of VTRNA1-2 in various tissues and organs. This can be done using techniques such as qRT-PCR, a reverse transcription polymerase technique that is widely used to detect the expression of specific genes.

Conclusion

In conclusion, Vault RNA 1-2 is a non-coding RNA molecule that has unique structure and function. Its potential as a drug target and biomarker has made it an attractive target for drug developers. The hairpin loop and stem-loop regions of VTRNA1 -2 make it a stable interaction partner for other molecules, which makes it a potential target for small molecules. Its unique structure and function also make it an attractive target for diagnostic tools that can detect and measure the expression of VTRNA1-2 in various tissues and organs. Further research is needed to fully understand the biology of VTRNA1-2 and its potential as a drug target and biomarker.

Protein Name: Vault RNA 1-2

More Common Targets

VTRNA1-3 | VTRNA2-1 | VTRNA3-1P | VWA1 | VWA2 | VWA3A | VWA3B | VWA5A | VWA5B1 | VWA5B2 | VWA7 | VWA8 | VWC2 | VWC2L | VWCE | VWDE | VWF | VXN | WAC | WAC-AS1 | WAKMAR1 | WAKMAR2 | WAPL | WARS1 | WARS2 | WARS2-AS1 | WAS | WASF1 | WASF2 | WASF3 | WASF4P | WASF5P | WASH complex | WASH2P | WASH3P | WASH4P | WASH5P | WASH6P | WASH7P | WASH8P | WASHC1 | WASHC2A | WASHC2C | WASHC3 | WASHC4 | WASHC5 | WASIR1 | WASL | WAVE1 complex | WBP1 | WBP11 | WBP11P1 | WBP1L | WBP2 | WBP2NL | WBP4 | WDCP | WDFY1 | WDFY2 | WDFY3 | WDFY3-AS2 | WDFY4 | WDHD1 | WDPCP | WDR1 | WDR11 | WDR11-DT | WDR12 | WDR13 | WDR17 | WDR18 | WDR19 | WDR20 | WDR24 | WDR25 | WDR26 | WDR27 | WDR3 | WDR31 | WDR33 | WDR35 | WDR35-DT | WDR36 | WDR37 | WDR38 | WDR4 | WDR41 | WDR43 | WDR44 | WDR45 | WDR45B | WDR46 | WDR47 | WDR48 | WDR49 | WDR5 | WDR53 | WDR54 | WDR55 | WDR59